AI-generated summary
In this animal study, 63 ovariectomized female rats were treated with photobiomodulation at 660, 810, or 940 nm, alone or with zoledronic acid, and bone mineral density and bone strength were measured. The authors report that all laser-treated groups differed significantly from untreated osteoporotic controls, with no significant difference between laser wavelengths or compared with zoledronic acid. The study was conducted in rats, so its applicability to humans is unclear.
- Participants
- 63
- Who or what was studied
- 63 adult female rats; ovariectomized to induce osteoporosis, plus a healthy sham-surgery control group
- Wavelengths
- 660, 810, 940 nm
- Limits stated in the abstract
- The study was conducted in rats, and the abstract does not address whether the findings apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 810 nm, 940 nm
- Energy density (fluence)
- 4 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Control group, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.